Recommendations for starting a grown up congenital heart disease (GUCH) unit

Fernando Tadeu Vasconcelos Amaral1, Paulo Henrique Manso1, André Schmidt1

  • 1Hospital das Clinicas, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, BR.

Insights

Advances in congenital heart disease (CHD) care allow adults to survive, requiring specialized multidisciplinary facilities. This review outlines essential structural and operational components for optimal adult CHD patient management.

Area of Science:

  • Cardiology
  • Adult Congenital Heart Disease (ACHD) Care

Background:

  • Significant advancements in diagnosis and treatment have increased the number of individuals with congenital heart disease (CHD) surviving into adulthood.
  • Adult patients with CHD present unique challenges due to diagnostic diversity and common co-morbidities.

Purpose of the Study:

  • To review the essential structural and organizational requirements for multidisciplinary facilities caring for adults with congenital heart disease.
  • To provide guidance on establishing and maintaining adequate care models for this growing patient population.

Main Methods:

  • Comprehensive literature review of international studies.
  • Incorporation of authors' clinical experience in adult congenital heart disease management.

Main Results:

  • Highlights the need for specialized facility characteristics and clear patient transfer criteria from pediatric settings.
  • Emphasizes the importance of multidisciplinary teams, robust outpatient and in-hospital assistance models, data storage, institutional support, and professional training.
  • Underscores the necessity of clinical research, particularly multicenter studies, for this heterogeneous group.

Conclusions:

  • Adequate attention for adult congenital heart disease patients necessitates specialized multidisciplinary facilities.
  • Effective management requires careful consideration of facility structure, staffing, care models, data management, institutional backing, training, and research.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
656
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
772
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
732
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
583
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
418
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
453